Optimizing Mental Health and Diabetes Management: Tailored Approaches for Treating Depression in Diabetic Patients
Keywords:
Diabetes, Depression, Treatment, Cognitive Therapy, Medication, Integrated ApproachesAbstract
This study aims to examine patient-specific factors that impact the efficacy of cognitive therapy, medication, and standard diabetes care in treating depression within the diabetic population. Depression often coexists with diabetes, posing significant challenges to effective treatment and overall health outcomes. To address this, we conducted a comprehensive review of existing literature, analyzing various patient-related elements that influence the success of interventions. Factors such as socioeconomic status, comorbidities, adherence to treatment, and individual psychological attributes play pivotal roles in determining the effectiveness of cognitive therapy, medication, and standard diabetes care. Furthermore, this research endeavors to propose evidence-based recommendations for integrated and tailored approaches that can optimize mental health outcomes while effectively managing diabetes in individuals experiencing concurrent depression. By identifying these patient-specific factors and offering tailored intervention strategies, this study aims to contribute to the enhancement of clinical practices, thereby improving the quality of life and overall well-being of diabetic individuals with comorbid depression.
References
Pan A, Lucas M, Sun Q, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010;170(21):1884-1891. DOI: 10.1001/archinternmed.2010.356.
Knol MJ, Twisk JWR, Beekman ATF, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49(5):837-845. DOI: 10.1007/s00125-006-0159-x.
Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398-2403. DOI: 10.2337/dc08-1341.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464-470. DOI: 10.2337/diacare.25.3.464.
Katon WJ, Lin EHB, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-2620. DOI: 10.1056/NEJMoa1003955.
Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29(3):725-731. DOI: 10.2337/diacare.29.03.06.dc05-2078.
Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care. 2006;29(4):823-829. DOI: 10.2337/diacare.29.04.06.dc05-1615.
Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;129(8):613-621. DOI: 10.7326/0003-4819-129-8-199810150-00004.
Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26(10):2822-2828. DOI: 10.2337/diacare.26.10.2822.
Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes. Diabetes Care. 2005;28(3):626-631. DOI: 10.2337/diacare.28.3.626.
Chida Y, Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med. 2008;70(7):741-756. DOI: 10.1097/PSY.0b013e31818105ba.
Bolier L, Haverman M, Westerhof GJ, et al. Positive psychology interventions: a meta-analysis of randomized controlled studies. BMC Public Health. 2013;13:119. DOI: 10.1186/1471-2458-13-119.
Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. Ann Intern Med. 1998;129(8):613-621. DOI: 10.7326/0003-4819-129-8-199810150-00004.
Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007;30(9):2222-2227. DOI: 10.2337/dc07-0158.
Lustman PJ, Clouse RE, Nix BD, et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2006;63(5):521-529. DOI: 10.1001/archpsyc.63.5.521.
Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069-1078. DOI: 10.2337/diacare.24.6.1069.
Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. Ann Intern Med. 1998;129(8):613-621. DOI: 10.7326/0003-4819-129-8-199810150-00004.
Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes. Diabetes Care. 2005;28(3):626-631. DOI: 10.2337/diacare.28.3.626.
Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care. 2006;29(4):823-829. DOI: 10.2337/diacare.29.04.06.dc05-1615.
Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29(3):725-731. DOI: 10.2337/diacare.29.03.06.dc05-2078.
Katon WJ, Lin EHB, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-2620. DOI: 10.1056/NEJMoa1003955.
This work is licensed under a 